Here are six things to know:
1. Nearly 33 percent of orthopedic surgeons are expected to utilize robotic systems by 2018, a RBC Capital Markets report found.
2. Currently, the report found nearly 18 percent of orthopedic surgeons use robotic systems.
3. Two primary reasons surgeons are not using these systems include insufficient scientific evidence and robotic systems’ escalated costs.
4. In 2015, Stryker sold 72 Mako systems, making the company among the key vendors in the market.
5. Additionally, Medtronic, also a key player, had sales reaching $645 million in traditional spine devices and plans to improve its MazorX system.
6. In the United States, there are currently 75 Navio systems, which Blue Belt Technologies constructed. Smith & Nephew acquired Blue Belt Technologies in 2015.
More device news:
Medtronic advances neurostimulation devices market; spinal cord stimulation devices dominate market share — 7 observations
Spinal fusion devices dominate global spinal implants & devices market: 7 market insights
Study: Patient-presentation of risk factors makes nonunion injuries predictable: 4 thoughts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
